ABBV:NYE-AbbVie Inc (USD)

COMMON STOCK | Drug Manufacturers-General | NYE

Last Closing Price

USD 116.22

Change

+0.47 (+0.41)%

Market Cap

USD 204.28B

Volume

7.09M

Average Target Price

USD 127.86 (+10.01%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production. The company was incorporated in 2012 and is based in North Chicago, Illinois.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-05-10 )

Largest Industry Peers for Drug Manufacturers-General

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
JNJ Johnson & Johnson

+1.77 (+1.05%)

USD443.73B 29.77 18.08
PFE Pfizer Inc

+0.28 (+0.71%)

USD220.78B 20.05 17.64
MRK Merck & Co., Inc

-0.24 (-0.31%)

USD198.54B 28.32 17.18
NVS Novartis AG

+0.02 (+0.02%)

USD196.62B 25.28 13.32
LLY Eli Lilly and Company

-0.66 (-0.34%)

USD187.41B 29.25 22.56
BMY Bristol-Myers Squibb Company

+0.26 (+0.40%)

USD143.88B 93.81 22.41
GSK GlaxoSmithKline plc

+0.18 (+0.47%)

USD94.77B 13.24 12.34
AGN Allergan plc

N/A

USD63.66B 22.00 28.44

ETFs Containing ABBV

Symbol Name Weight Mer Price(Change) Market Cap
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

-0.16 (-0.31%)

USD1.07B
UC97:LSE UBS(Lux)Fund Solutions &#.. 0.00 % 0.20 %

+0.04 (+0.22%)

USD0.31B
SPYD:F SPDR S&P US Dividend Aris.. 0.00 % 0.35 %

+0.93 (+1.62%)

USD3.09B
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.15 %

+0.09 (+1.16%)

USD1.47B
QDVD:F iShares MSCI USA Quality .. 0.00 % 0.35 %

+0.49 (+1.40%)

USD0.28B
IS3S:F iShares Edge MSCI World V.. 0.00 % 0.30 %

+0.20 (+0.65%)

USD3.82B
SUSD:LSE SPDR Bloomberg Barclays 0.. 0.00 % 0.20 %

N/A

USD0.09B
XUHC:LSE Xtrackers (IE) Plc - Xtra.. 0.00 % 0.12 %

+0.10 (+0.20%)

USD0.47B
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.12 %

-22.50 (-0.63%)

USD0.77B
XDWH:LSE Xtrackers (IE) Plc - Xtra.. 0.00 % 0.25 %

+0.09 (+0.20%)

USD1.33B
WHEA:LSE SPDR MSCI World Health Ca.. 0.00 % 0.30 %

+0.19 (+0.36%)

USD0.32B
UQLT:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.35 %

N/A

USD0.01B
UDVD:LSE SPDR® S&P US Dividend Ar.. 0.00 % 0.35 %

+1.21 (+1.73%)

USD2.77B
UC86:LSE UBS(Lux)Fund Solutions &#.. 0.00 % 0.18 %

N/A

USD0.33B
UBUT:F UBS (Irl) ETF plc - Facto.. 0.00 % 0.25 %

-0.10 (-0.33%)

USD0.23B
UC85:LSE UBS(Lux)Fund Solutions &#.. 0.00 % 0.23 %

-5.50 (-0.32%)

USD0.08B
UC84:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.00 %

-1.00 (-0.08%)

USD0.12B
UC82:LSE UBS(Lux)Fund Solutions &#.. 0.00 % 0.23 %

-0.52 (-0.04%)

USD0.06B
UC81:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.18 %

N/A

USD0.33B
UC76:LSE UBS(Lux)Fund Solutions &#.. 0.00 % 0.18 %

+0.02 (+0.08%)

USD0.12B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.15 %

+0.18 (+0.49%)

USD0.20B
IWVU:LSE iShares Edge MSCI World V.. 0.00 % 0.30 %

+0.05 (+0.95%)

USD5.27B
IWVL:LSE iShares Edge MSCI World V.. 0.00 % 0.30 %

+0.34 (+0.91%)

USD5.61B
IUHC:LSE iShares S&P 500 Health Ca.. 0.00 % 0.15 %

+0.06 (+0.63%)

USD1.48B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.15 %

-2.51 (-0.37%)

USD1.69B
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.29 %

N/A

USD0.04B
SYBR:F SPDR Bloomberg Barclays 1.. 0.00 % 0.20 %

-0.09 (-0.32%)

USD0.10B
UBUX:F UBS (Irl) ETF plc - Facto.. 0.00 % 0.35 %

+0.12 (+0.37%)

USD0.04B
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.29 %

N/A

USD0.02B
UBUT:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.25 %

-0.17 (-0.55%)

USD0.23B
XUHC:XETRA Xtrackers (IE) Plc - Xtra.. 0.00 % 0.12 %

+0.06 (+0.15%)

USD0.47B
XDWH:XETRA Xtrackers (IE) Plc - Xtra.. 0.00 % 0.25 %

+0.06 (+0.16%)

USD1.33B
XDEV:XETRA Xtrackers (IE) Plc - Xtra.. 0.00 % 0.25 %

+0.23 (+0.73%)

USD0.79B
WTEU:XETRA WisdomTree US Equity Inco.. 0.00 % 0.29 %

+0.28 (+1.55%)

USD0.02B
WTDY:XETRA WisdomTree US Equity Inco.. 0.00 % 0.35 %

+0.30 (+1.58%)

USD0.19M
WTD9:XETRA WisdomTree US Equity Inco.. 0.00 % 0.29 %

+0.28 (+1.44%)

USD0.04B
VDIV:XETRA VanEck Vectors™ Morning.. 0.00 % 0.00 %

+0.26 (+0.89%)

USD0.04B
UEF9:XETRA UBS(Lux)Fund Solutions &#.. 0.00 % 0.18 %

-0.03 (-0.17%)

USD0.12B
UEF8:XETRA UBS(Lux)Fund Solutions &#.. 0.00 % 0.23 %

+0.01 (+0.07%)

USD0.61B
UEF0:XETRA UBS(Lux)Fund Solutions &#.. 0.00 % 0.23 %

-0.01 (-0.06%)

USD0.38B
UBUX:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.35 %

-0.13 (-0.42%)

USD0.04B
SYBR:XETRA SPDR Bloomberg Barclays 1.. 0.00 % 0.20 %

-0.02 (-0.07%)

USD0.07B
UEF0:F UBS ETF - Bloomberg Barcl.. 0.00 % 0.23 %

-0.15 (-0.77%)

USD0.38B
SYBN:XETRA SPDR Bloomberg Barclays 1.. 0.00 % 0.20 %

-0.09 (-0.31%)

USD0.10B
SPYD:XETRA SPDR S&P US Dividend Aris.. 0.00 % 0.35 %

+0.94 (+1.63%)

USD3.09B
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.15 %

+0.03 (+0.42%)

USD1.48B
QDVD:XETRA iShares MSCI USA Quality .. 0.00 % 0.35 %

+0.43 (+1.24%)

USD0.28B
IS3S:XETRA iShares Edge MSCI World V.. 0.00 % 0.30 %

+0.22 (+0.71%)

USD5.27B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.15 %

+0.40 (+1.36%)

USD0.19B
XDWH:F Xtrackers (IE) Plc - Xtra.. 0.00 % 0.25 %

+0.15 (+0.40%)

USD1.10B
WTEU:F WisdomTree US Equity Inco.. 0.00 % 0.29 %

+0.26 (+1.44%)

USD0.02B
WTDY:F WisdomTree US Equity Inco.. 0.00 % 0.35 %

+0.29 (+1.53%)

USD0.19M
WTD9:F WisdomTree US Equity Inco.. 0.00 % 0.29 %

+0.27 (+1.38%)

USD0.04B
UEF9:F UBS(Lux)Fund Solutions &#.. 0.00 % 0.18 %

-0.08 (-0.52%)

USD0.12B
UEF7:F UBS(Lux)Fund Solutions &#.. 0.00 % 0.18 %

-0.04 (-0.34%)

USD0.33B
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.35 %

+3.05 (+0.18%)

USD7.08M
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.29 %

N/A

USD0.04B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

-0.02 (-0.09%)

USD0.98B
JHMH John Hancock Multifactor .. 0.00 % 0.40 %

-0.21 (-0.44%)

USD0.05B
SDYL UBS ETRACS Monthly Pay 2x.. 0.00 % 0.30 %

N/A

USD9.68M
SDY SPDR S&P Dividend ETF 0.00 % 0.35 %

+0.46 (+0.36%)

USD20.85B
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

-0.41 (-0.47%)

USD0.13B
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.03 (+0.37%)

USD1.30M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.03 (+0.37%)

USD1.30M
RDIV Invesco S&P Ultra Dividen.. 0.00 % 0.39 %

-0.03 (-0.07%)

USD0.96B
PWV Invesco Dynamic Large Cap.. 0.00 % 0.56 %

-0.01 (-0.02%)

USD0.74B
PPH VanEck Vectors Pharmaceut.. 0.00 % 0.35 %

+0.32 (+0.45%)

USD0.25B
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

-0.27 (-0.34%)

USD0.36B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.14 %

-0.71 (-0.54%)

USD41.14B
LNGR Global X Aging Population.. 0.00 % 0.50 %

N/A

USD0.04B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

-0.82 (-0.31%)

USD2.58B
WBIG WBI BullBear Yield 3000 E.. 0.00 % 1.14 %

+0.05 (+0.17%)

USD0.05B
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

+0.02 (+0.02%)

USD2.81B
IBDQ iShares iBonds Dec 2025 T.. 0.00 % 0.10 %

-0.01 (-0.04%)

USD1.08B
IBDN iShares iBonds Dec 2022 T.. 0.00 % 0.10 %

+0.02 (+0.08%)

USD1.57B
IBDL iShares iBonds Dec 2020 T.. 0.00 % 0.10 %

N/A

USD0.95B
FHLC Fidelity MSCI Health Care.. 0.00 % 0.08 %

-0.38 (-0.61%)

USD2.62B
FDRR Fidelity Dividend ETF for.. 0.00 % 0.29 %

-0.09 (-0.21%)

USD0.43B
FDL First Trust Morningstar D.. 0.00 % 0.45 %

+0.16 (+0.46%)

USD1.66B
ESGW Columbia Sustainable Glob.. 0.00 % 0.40 %

N/A

USD0.01B
DHS WisdomTree U.S. High Divi.. 0.00 % 0.38 %

+0.38 (+0.47%)

USD0.79B
DEW WisdomTree Global High Di.. 0.00 % 0.58 %

+0.10 (+0.19%)

USD0.07B
CURE Direxion Daily Healthcare.. 0.00 % 1.01 %

+0.39 (+0.39%)

USD0.16B
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

-1.50 (-0.62%)

USD16.90B
WBIL WBI BullBear Quality 3000.. 0.00 % 1.23 %

+0.01 (+0.04%)

USD0.05B
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.29 %

-4.36 (-0.28%)

USD0.02B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.65 %

+0.06 (+0.52%)

USD0.15B
BSUS:LSE UBS(Lux)Fund Solutions &#.. 0.00 % 0.25 %

-3.00 (-0.27%)

USD0.09B
PHE-B:CA Purpose Tactical Hedged E.. 0.00 % 0.97 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.65 %

N/A

N/A
ZWH-U:CA BMO US High Dividend Cove.. 0.00 % 0.65 %

N/A

N/A
ZDY-U:CA BMO US Dividend ETF (USD) 0.00 % 0.30 %

+0.16 (+0.57%)

N/A
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.85 %

+0.05 (+0.59%)

N/A
LS:CA Middlefield Healthcare & .. 0.00 % 0.85 %

-0.17 (-1.62%)

USD0.08B
AWTM Aware Ultra-Short Duratio.. 0.00 % 0.25 %

-0.01 (-0.01%)

USD0.15B
DSTL Distillate U.S. Fundament.. 0.00 % 0.39 %

-0.14 (-0.32%)

USD0.33B
SDGA Impact Shares Sustainable.. 0.00 % 0.75 %

-0.15 (-0.56%)

USD4.67M
IGIB iShares 5-10 Year Investm.. 0.00 % 0.06 %

-0.13 (-0.22%)

USD11.28B
QUIG:CA Mackenzie US Investment G.. 0.00 % 0.15 %

N/A

USD0.40B
XHC:CA iShares Global Healthcare.. 0.00 % 0.63 %

+0.10 (+0.16%)

USD0.44B
VSMV VictoryShares US Multi-Fa.. 0.00 % 0.35 %

+0.07 (+0.19%)

USD0.16B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

-0.30 (-1.16%)

USD0.02B
NUBD Nuveen ESG U.S. Aggregate.. 0.00 % 0.20 %

-0.06 (-0.23%)

USD0.24B
WBIY WBI Power Factor High Div.. 0.00 % 0.70 %

+0.05 (+0.18%)

USD0.06B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.45 %

-0.03 (-0.14%)

USD0.01B
CAPS:CA Evolve Active US Core Equ.. 0.00 % 0.70 %

N/A

USD3.62M
HID:CA WisdomTree U.S. High Divi.. 0.00 % 0.40 %

N/A

USD4.31M
HHL:CA Harvest Healthcare Leader.. 0.00 % 0.85 %

+0.02 (+0.24%)

USD0.33B
ZWH:CA BMO US High Dividend Cove.. 0.00 % 0.65 %

-0.13 (-0.58%)

USD0.83B
ZUQ:CA BMO MSCI USA High Quality.. 0.00 % 0.30 %

-0.84 (-1.62%)

USD0.43B
ZDY:CA BMO US Dividend ETF (CAD) 0.00 % 0.30 %

-0.17 (-0.51%)

USD0.47B
XLV Health Care Select Sector.. 0.00 % 0.12 %

+0.16 (+0.13%)

USD25.62B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.15 %

+0.13 (+0.44%)

USD0.19B

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers-General)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.46% 88% B+ 48% F
Dividend Return 2.43% 88% B+ 85% B
Total Return 10.89% 88% B+ 52% F
Trailing 12 Months  
Capital Gain 32.22% 100% A+ 41% F
Dividend Return 5.64% 100% A+ 71% C-
Total Return 37.86% 100% A+ 43% F
Trailing 5 Years  
Capital Gain 85.36% 88% B+ 72% C-
Dividend Return 28.25% 100% A+ 82% B-
Total Return 113.60% 88% B+ 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 15.83% 88% B+ 81% B-
Dividend Return 4.33% 88% B+ 80% B-
Total Return 20.16% 88% B+ 84% B
Risk Return Profile  
Volatility (Standard Deviation) 29.78% 13% F 34% F
Risk Adjusted Return 67.68% 75% C 78% C+
Market Capitalization 204.28B 75% C 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers-General)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 39.74 25% F 19% F
Price/Book Ratio 15.63 25% F 6% F
Price / Cash Flow Ratio 11.61 75% C 41% F
EV/EBITDA 42.20 13% F 11% F
Management Effectiveness  
Return on Equity 163.56% 100% A+ 99% A+
Return on Invested Capital 17.48% 75% C 90% A-
Return on Assets 8.48% 75% C 91% A-
Debt to Equity Ratio 593.10% 13% F 4% F
Technical Ratios  
Short Ratio 2.44 38% F 43% F
Short Percent 1.06% 33% F 83% B
Beta 0.81 13% F 70% C-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.